1H-NMR metabolite profiles of different strains of Plasmodium falciparum
暂无分享,去创建一个
Kiaran Kirk | K. Kirk | D. V. van Schalkwyk | Adele M. Lehane | Rowena E. Martin | R. Teng | P. Junankar | M. Winterberg | Markus Winterberg | Sarah H. Shafik | R. Summers | Rongwei Teng | Robert L. Summers | Donelly A. van Schalkwyk | Pauline R. Junankar | S. Shafik
[1] J. Whisstock,et al. Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase , 2009, Proceedings of the National Academy of Sciences.
[2] C. D. Fitch. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. , 2004, Life sciences.
[3] G. Curley,et al. Aminopeptidases from Plasmodium falciparum, Plasmodium chabaudi chabaudi and Plasmodium berghei , 1994, The Journal of eukaryotic microbiology.
[4] T. Tiffert,et al. Excess haemoglobin digestion by malaria parasites: a strategy to prevent premature host cell lysis. , 2004, Blood cells, molecules & diseases.
[5] S. Dalal,et al. Roles for Two Aminopeptidases in Vacuolar Hemoglobin Catabolism in Plasmodium falciparum* , 2007, Journal of Biological Chemistry.
[6] K. Kirk,et al. Metabolite profiling of the intraerythrocytic malaria parasite Plasmodium falciparum by 1H NMR spectroscopy , 2009, NMR in biomedicine.
[7] S. Schaffner,et al. Harnessing genomics and genome biology to understand malaria biology , 2012, Nature Reviews Genetics.
[8] Pardis C Sabeti,et al. A genome-wide map of diversity in Plasmodium falciparum , 2007, Nature Genetics.
[9] P. Roepe,et al. Chloroquine Resistance Modulated in Vitro by Expression Levels of the Plasmodium falciparum Chloroquine Resistance Transporter* , 2003, Journal of Biological Chemistry.
[10] M. Mehta,et al. Malaria parasite‐infected erythrocytes inhibit glucose utilization in uninfected red cells , 2005, FEBS letters.
[11] A. Bröer,et al. The Astroglial ASCT2 Amino Acid Transporter as a Mediator of Glutamine Efflux , 1999, Journal of neurochemistry.
[12] Rowena E. Martin,et al. Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics , 2012, Cellular and Molecular Life Sciences.
[13] D. Fidock,et al. Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. , 2005, Biochemistry.
[14] G. McVean,et al. Recombination Hotspots and Population Structure in Plasmodium falciparum , 2005, PLoS biology.
[15] W. Stein,et al. Dissecting the components of quinine accumulation in Plasmodium falciparum , 2008, Molecular microbiology.
[16] K. Becker,et al. SELDI‐TOF‐MS analysis of chloroquine resistant and sensitive Plasmodium falciparum strains , 2007, Proteomics.
[17] Jun Liu,et al. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. McCarthy,et al. Saquinavir Inhibits the Malaria Parasite's Chloroquine Resistance Transporter , 2012, Antimicrobial Agents and Chemotherapy.
[19] John C. Wootton,et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum , 2002, Nature.
[20] X. Su,et al. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. , 2002, Molecular pharmacology.
[21] K. Kirk,et al. Choline uptake into the malaria parasite is energized by the membrane potential. , 2004, Biochemical and Biophysical Research Communications - BBRC.
[22] K. Kirk,et al. Chloroquine Resistance-Conferring Mutations in pfcrt Give Rise to a Chloroquine-Associated H+ Leak from the Malaria Parasite's Digestive Vacuole , 2008, Antimicrobial Agents and Chemotherapy.
[23] S. Bröer. Xenopus laevis Oocytes. , 2010, Methods in molecular biology.
[24] K. Kirk,et al. Efflux of a range of antimalarial drugs and ‘chloroquine resistance reversers’ from the digestive vacuole in malaria parasites with mutant PfCRT , 2010, Molecular microbiology.
[25] K. Kirk,et al. Inhibition of hexose transport and abrogation of pH homeostasis in the intraerythrocytic malaria parasite by an O‐3‐hexose derivative , 2004, FEBS letters.
[26] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[27] F. Ataullakhanov,et al. What Determines the Intracellular ATP Concentration , 2002, Bioscience reports.
[28] Kiaran Kirk,et al. The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily. , 2004, Molecular biology and evolution.
[29] I. Gluzman,et al. Generation of hemoglobin peptides in the acidic digestive vacuole of Plasmodium falciparum implicates peptide transport in amino acid production. , 1997, Molecular and biochemical parasitology.
[30] Ruth H. Hughes,et al. PfCRT and the trans‐vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX , 2006, Molecular microbiology.
[31] Kellen L. Olszewski,et al. Metabolic QTL Analysis Links Chloroquine Resistance in Plasmodium falciparum to Impaired Hemoglobin Catabolism , 2014, PLoS genetics.
[32] X. Su,et al. Genome-Wide Compensatory Changes Accompany Drug- Selected Mutations in the Plasmodium falciparum crt Gene , 2008, PloS one.
[33] J. Wootton,et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. , 2000, Molecular cell.
[34] Erin E. Carlson,et al. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. , 2006, Analytical chemistry.
[35] Chloroquine transport in Plasmodium falciparum. 1. Influx and efflux kinetics for live trophozoite parasites using a novel fluorescent chloroquine probe. , 2009, Biochemistry.
[36] K. Kirk,et al. Plasmodium falciparum culture: the benefits of shaking. , 2010, Molecular and biochemical parasitology.
[37] H. Vial,et al. Phospholipids in parasitic protozoa. , 2003, Molecular and biochemical parasitology.
[38] Ruth H. Hughes,et al. Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs. , 2004, Blood.
[39] L. Tilley,et al. Mitochondrial metabolism of sexual and asexual blood stages of the malaria parasite Plasmodium falciparum , 2013, BMC Biology.
[40] J. Whisstock,et al. Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials. , 2010, Trends in biochemical sciences.
[41] David A. Fidock,et al. Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations , 2002, Science.
[42] D. B. Gordon,et al. Global Mass Spectrometry Based Metabolomics Profiling of Erythrocytes Infected with Plasmodium falciparum , 2013, PloS one.
[43] Thomas E. Wellems,et al. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross , 1990, Nature.
[44] L. Mokrasch. Use of 2,4,6-trinitrobenzenesulfonic acid for the coestimation of amines, amino acids, and proteins in mixtures , 1967 .
[45] I. Gluzman,et al. A Plasmodium falciparum Dipeptidyl Aminopeptidase I Participates in Vacuolar Hemoglobin Degradation* , 2004, Journal of Biological Chemistry.
[46] C. Lambros,et al. Synchronization of Plasmodium falciparum erythrocytic stages in culture. , 1979, The Journal of parasitology.
[47] J. M. May,et al. Inhibition of aldose reductase in human erythrocytes by vitamin C. , 1999, Diabetes research and clinical practice.
[48] Kiaran Kirk,et al. Cell volume control in the Plasmodium-infected erythrocyte. , 2004, Trends in parasitology.
[49] Kellen L. Olszewski,et al. Host-parasite interactions revealed by Plasmodium falciparum metabolomics. , 2009, Cell host & microbe.